Medication Incidents in Primary Care Medicine
NCT02295371 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 213
Last updated 2016-01-12
Summary
Prospective reporting of safety incidents concerning drug treatment by approximately 120 primary care physicians or pediatricians during 2015.
Conditions
- Medication Incidents
Sponsors & Collaborators
-
University of Lausanne
collaborator OTHER -
University of Zurich
lead OTHER
Principal Investigators
-
Markus P. Gnädinger, MD · Institute for General Medicine, Zurich University Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2015-12-31
- Completion
- 2016-01-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly and and Healthy Younger Adult Participants
NCT02345148 ·Status: COMPLETED ·Phase: PHASE1
-
Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling
NCT02037035 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls
NCT03649555 ·Status: COMPLETED ·Phase: PHASE1
-
Using Sensors to Measure Drug Concentrations in Exhaled Breath
NCT04071145 ·Status: UNKNOWN
-
Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine
NCT00847418 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Repeat Doses of DMT in Healthy Subjects
NCT05559931 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
NCT00244465 ·Status: COMPLETED
-
Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin
NCT03011970 ·Status: COMPLETED ·Phase: PHASE1
-
Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling
NCT05219604 ·Status: TERMINATED ·Phase: PHASE4
-
Experimental Pain Reporting Accuracy and Placebo Response
NCT03950999 ·Status: UNKNOWN ·Phase: NA
-
Effects of H1-Antagonist on Cognition
NCT00846950 ·Status: COMPLETED ·Phase: NA
-
Oxytocin and Emotion Recognition
NCT01216605 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)
NCT05695495 ·Status: COMPLETED ·Phase: PHASE1
-
The Influence of Oxytocin on Socio-communicative Sensitivity
NCT03096249 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging
NCT01296802 ·Status: COMPLETED ·Phase: NA
-
1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
NCT02333071 ·Status: COMPLETED ·Phase: PHASE3
-
Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome
NCT02710084 ·Status: COMPLETED ·Phase: PHASE2
-
Endocrine and Emotional Effects of Lisdexamfetamine and d-Amphetamine.
NCT02668926 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of GH002 in Healthy Volunteers
NCT05753956 ·Status: COMPLETED ·Phase: PHASE1
-
Emergency Department Crowding in Relation to In-hospital Adverse Medical Events
NCT01116323 ·Status: COMPLETED
-
Influence of Oxytocin on Resting State Neurophysiological Measures
NCT03255148 ·Status: COMPLETED ·Phase: PHASE1
-
Oxytocin Administration and Emotion Recognition Abilities in Adults Reporting Adverse Childhood Experiences
NCT03335085 ·Status: COMPLETED ·Phase: NA
-
Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical Settings
NCT07348172 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Multimodal Educative Data Feedback for Deprescribing BZD and Related Drugs in Outpatients: a Cluster RCT
NCT05859555 ·Status: COMPLETED ·Phase: NA
-
Influence of a Medicinal Cannabinoid Agonist on Responses to Food Images and Food Intake
NCT02310347 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA